MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
$1,394,121
EPS
$0.06
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
General and administrative expenses
456,538 452,603.5 225,579 269,810
Loss from operations
-456,538 -452,603.5* -225,579 -269,810
Change in fair value of over-allotment liability
-0* --
Interest earned on cash held in trust account
1,850,659 1,979,800* 2,192,321 2,144,153
Total other income
1,850,659 1,979,800* 2,192,321 2,144,153
Net income
1,394,121 1,527,196.5 1,966,742 1,874,343
Basic EPS
0.06 0.08 0.08 -
Diluted EPS
0.06 0.08 0.08 -
Basic Average Shares
19,199,029 19,199,029 19,199,029 -
Diluted Average Shares
19,199,029 19,199,029 19,199,029 -
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest earned on cashheld in trust account$1,850,659 Total other income$1,850,659 Net income$1,394,121 Loss from operations-$456,538 General andadministrative expenses$456,538

Oaktree Acquisition Corp. III Life Sciences (OACCW)

Oaktree Acquisition Corp. III Life Sciences (OACCW)